Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Characterize Patients Treated With Visanne for Their Endometriosis Under Real-life Practice Conditions and Evaluate Their Quality of Life at Baseline and After 6 Months of Treatment With Visanne.

NCT01595724 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01595724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01595724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Characterize Patients Treated With Visanne for Their Endometriosis Under Real-life Practice Conditions and Evaluate Their Quality of Life at Baseline and After 6 Months of Treatment With Visanne.
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
May 31, 2012
Completion date
May 31, 2015
Enrollment
3,006 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis